← FDA Drug Approvals (Drugs@FDA)

ZILRETTA

NDA · New Drug Application · Sponsor: PACIRA PHARMS INC · Approved 2017-10-06

Drug application

FDA Application #

NDA208845

Application type

New Drug Application

Brand name

ZILRETTA

Generic name

TRIAMCINOLONE ACETONIDE EXTENDED-RELEASE INJECTABLE SUSPENSION

Active ingredients

TRIAMCINOLONE ACETONIDE

Dosage form

FOR SUSPENSION, EXTENDED RELEASE

Route

INTRA-ARTICULAR

Marketing status

Prescription

Sponsor

PACIRA PHARMS INC

Manufacturer

Pacira Pharmaceuticals, Inc.

First approval

2017-10-06

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown